Get the latest news on IXICO stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on PHYOF performance

Latest IXICO Stock News | OTC:PHYOF | Benzinga

IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

Comments

IXICO Stock News

News

Latest IXICO Stock News | OTC:PHYOF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga